Evidence map›Paper›PMID 32727223›Full record

ReviewCritical reviews in biochemistry and molecular biology2020

The multi-functional eyes absent proteins.

Rashmi S Hegde, Kaushik Roychoudhury, Ram Naresh Pandey

Open access · bronzeAbstract readReviewVideo-Audio Media
In one paragraph

Review in Critical reviews in biochemistry and molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. The Eyes Absent Proteins: Unusual HAD Family Tyrosine Phosphatases.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rashmi S HegdeDivision of Developmental Biology, Cincinnati Children's Hospital Research Foundation, Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH, USA.ORCID 0000-0003-2524-7280
Kaushik RoychoudhuryDivision of Developmental Biology, Cincinnati Children's Hospital Research Foundation, Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
Ram Naresh PandeyDivision of Developmental Biology, Cincinnati Children's Hospital Research Foundation, Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
Cincinnati Children's Hospital Medical Center · US

Funding

A ROLE FOR EYA3 IN VASCULAR REMODELING AND PULMONARY ARTERIAL HYPERTENSIONR01HL152094 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI HEGDE, RASHMI S. · 2020 to 2023
$2.3M
Linked regulation of tumor angiogenesis and chemo-resistanceR01CA207068 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI HEGDE, RASHMI S. · 2017 to 2021
$1.8M
NCI NIH HHS R01 CA207068NHLBI NIH HHS R01 HL152094
6 · The paper itself

Abstract

The Eyes Absent (EYA) proteins are the only known instance of a single polypeptide housing the following three separable biochemical activities: tyrosine phosphatase, threonine phosphatase, and transactivation. This uniquely positions the EYAs to participate in both transcriptional regulation and signal transduction pathways. But it also complicates the assignment of biological roles to individual biochemical activities through standard loss-of-function experiments. Nevertheless, there is an emerging literature linking developmental and pathological functions with the various EYA activities, and a growing list of disease states that might benefit from EYA-targeted therapeutics. There also remain multiple unresolved issues with significant implications for our understanding of how the EYAs might impact such ubiquitous signaling cascades as the MYC and Notch pathways. This review will describe the unique juxtaposition of biochemical activities in the EYAs, their interaction with signaling pathways and cellular processes, emerging evidence of roles in disease states, and the feasibility of therapeutic targeting of individual EYA activities. We will focus on the phosphatase activities of the vertebrate EYA proteins and will examine the current state of knowledge regarding: • substrates and signaling pathways affected by the EYA tyrosine phosphatase activity; • modes of regulation of the EYA tyrosine phosphatase activity; • signaling pathways that implicate the threonine phosphatase activity of the EYAs including a potential interaction with PP2A-B55α; • the interplay between the two phosphatase activities and the transactivation function of the EYAs; • disease states associated with the EYAs and the current state of development of EYA-targeted therapeutics.

Indexed as

Signal TransductionAnimalsHumansPhosphoprotein PhosphatasesProtein Tyrosine PhosphatasesTrans-ActivatorsPhosphoprotein PhosphatasesProtein Tyrosine PhosphatasesTrans-ActivatorsDNA damage repairEYAEyes AbsentH2AXMYCNotchPTPthreonine phosphatase

Identifiers

PMID32727223
PMCPMC7727457
OpenAlexW3046823655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.